Understanding inflammatory arthritis
Evaluation and Management principles
CDC: Census Bureau 2004
3
What is inflammation?
 Normal body defence mechanism
 Increased blood flow
 Blood cells produce chemical messengers t...
Acute vs Chronic Inflammatory Arthritis
Acute Arthritis
Rapid onset (hours or days)
Severe symptoms
Mediated by components...
Diversity of Rheumatologic Diseases:
Inflammatory and Immune Responses
Inflammatory Diseases (innate immunity)
Osteoarthri...
Pattern of Joint Involvement is Distinct in Different Diseases
Monoarticular vs Polyarticular
Mono Poly
Gout RA
Infection ...
Multiple Factors Contribute to the Development of Arthritis
Nature Reviews Immunology, 2007
Genetic Basis of Rheumatic Diseases:
Genotype contributes to rheumatic disease susceptibility
________ Twin Studies_______...
October 2009: >30 RA Risk Loci
Plenge RM, ACR Annual Meeting Presentation, October 2009
Together explain ~35% of the genet...
Oral Health and RA
 Periodontal disease more common in people with
RA than controls
 Oral bacterium, Porphyromonas gingi...
11
Symptoms
 Joint pain
 Joint swelling
 Morning stiffness
 Fatigue
 Weight loss
 Flu-like symptoms
12
13
Rheumatoid Arthritis: PIP Swelling
 Swelling is confined to
the area of the joint
capsule
 Synovial thickening
feels lik...
Rheumatoid Arthritis:
Ulnar Deviation and MCP Swelling
 An across-the-room
diagnosis
 Prominent ulnar
deviation in the r...
Rheumatoid Arthritis
Early erosion at the tip of the ulnar styloid
2010 ACR/EULAR
Classification Criteria for RA
JOINT DISTRIBUTION (0-5)
1 large joint 0
2-10 large joints 1
1-3 small joint...
18
Extraarticular ?
 Eyes: dryness, inflammation, uveitis
 Lungs: fluid, inflammation, nodules
 Skin: nodules, ulcers, ...
Spondyloarthritis, Psoriasis and PsA
Spondyloarthritis (SpA)
 The prevalence of SpA is comparable to that of RA (0.5–1.9%...
AS: A Debilitating Rheumatic DiseaseAS: A Debilitating Rheumatic Disease
1
Linden VD et al. Chapter 10. In: Firestein, Bud...
Ankylosing
Spondylitis
“Bamboo Spine”
Repeated process of healing
and bone formation leads to
formation of syndesmophytes
...
• Mortality figures parallel RAMortality figures parallel RA6,7,86,7,8
 ““Rare”Rare”
 ““Not” a serious disease, function...
AS: Signs and SymptomsAS: Signs and Symptoms
Axial manifestations:
• Chronic low back pain
• With or without buttock pain
...
Peripheral manifestations
Enthesitis Peripheral arthritis Dactylitis
AS: Signs and SymptomsAS: Signs and Symptoms
50% pati...
Why are Dactylitis and Enthesitis Important?
The first abnormality to appear in swollen
joints associated with
spondyloart...
AS: Extra-skeletal Signs and SymptomsAS: Extra-skeletal Signs and Symptoms
Other common symptoms seen during the early
sta...
AS:AS: Extra-articular Manifestations (EAM)Extra-articular Manifestations (EAM)
EAM Prevalence in AS
Patients (%)
Anterior...
Spondyloarthritis and Classification
Criteria
Spondyloarthropathies
Axial and Peripheral
AMOR criteria (1990)
ESSG criteri...
ASAS Classification Criteria for Axial SpAASAS Classification Criteria for Axial SpA
In patients with back pain ≥3 months ...
30
Psoriatic Arthritis
Psoriatic Arthritis
ACR Slide Collection on the Rheumatic Diseases; 3rd
edition. 1994.
Data on file, Centocor, Inc.
Pso patients6-8
• Psychosocial burden
• Reactive depression
• Higher suicidal ideation
• Alcoholism

Metabolic Syndrome3-...
Classical Description of PsA Using the
Diagnostic Criteria of Moll and Wright
 Including 5 clinical patterns:
x Asymmetri...
Paradigm shift in the treatment of
inflammatory arthritis
 Rationale for Treatment
x Large body of evidence which shows j...
It’s like an Iceberg
It’s what you don’t see!
Approach to Inflammatory Arthritis
 “Window of Opportunity”
x Early and aggressive treatment may have
long-term benefits
...
A Fire in the Joints
If there’s a fire in
the kitchen do you
wait until it spreads
to the living room
or do you try and
pu...
39
Principles of Treatment
 Early diagnosis
 Early initiation of treatment
 Regular assessment (Disease Activity Scores...
40
Reduction of Joint Damage
Disease-modifying Anti-
Rheumatic Drugs
Methotrexate
Sulfasalazine
Leflunomide
Hydroxychl...
41
42
43
Upcoming SlideShare
Loading in …5
×

Inflammatory arthritis an overview

516 views

Published on

a review of selescted inflammatory arthritis : RA, SpA, SpA and AS

0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
516
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
25
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide
  • #### PLEASE DO NOT DELETE CONTENT BELOW THIS LINE ! ####
    ########### Presentation 'GLM_OPT02_GLM Optimize PsA_r00_05AUG10.ppt' created on Wednesday, 4 August, 2010 ###########
    Author: GIB1 Purpose: Optimize slide decks QA: 04-Aug-10 Review By: 04-Feb-11
    Review Type: Scientific, Reference Check, Compliance Review and HCC Office Slide: 9/108 Golimumab-Specific Deck: Yes
  • #### PLEASE DO NOT DELETE CONTENT BELOW THIS LINE ! ####
    ########### Presentation 'REM_OPT05_AS_r02_02SEP10.ppt' created on Thursday, 2 September, 2010 ###########
    Author: GIB1 Purpose: Optimize slide decks QA: 27-Mar-09 Review By: 18-Sep-09
    Review Type: Scientific, Reference Check, Compliance Review and HCC Office Slide: 24/168 Golimumab-Specific Deck: No
  • Classic Bamboo Spine x-ray of AS, this is the usual fate of patients with spinal involvement in AS.
    Syndesmophytes are the bony bridges that form between bones as a consequence of inflammation.
  • ANIMATED SLIDE (CLICK FOR EACH BULLET POINT)
    Perceptions about AS are still wrong today. Physicians diagnose AS late, because they think it is rare, not a serious disease and that patients don’t die as a result of the disease. Patients often seek care late for the same reasons.
  • Pictures are from the CRI website (http://www.cri-net.com/) and are free for use
    IRM des sacro-iliaques – Rehaussement du signal après injection de gadolinium témoignant de l’existence d’une sacro-iliite droite (spondylarthrite ankylosante débutante)
    #### PLEASE DO NOT DELETE CONTENT BELOW THIS LINE ! ####
    ########### Presentation 'REM_OPT05_AS_r02_02SEP10.ppt' created on Thursday, 2 September, 2010 ###########
    Author: GIB1 Purpose: Optimize slide decks QA: 27-Mar-09 Review By: 18-Sep-09
    Review Type: Scientific, Reference Check, Compliance Review and HCC Office Slide: 16/168 Golimumab-Specific Deck: No
  • 2 first Pictures come from following website: http://www.rheumatologie-berlin.de/probability/early.php?m_id=9&s_id=91, the third one from the CRI website (http://www.cri-net.com/)
    #### PLEASE DO NOT DELETE CONTENT BELOW THIS LINE ! ####
    ########### Presentation 'REM_OPT05_AS_r02_02SEP10.ppt' created on Thursday, 2 September, 2010 ###########
    Author: GIB1 Purpose: Optimize slide decks QA: 27-Mar-09 Review By: 18-Sep-09
    Review Type: Scientific, Reference Check, Compliance Review and HCC Office Slide: 19/168 Golimumab-Specific Deck: No
  • Dactylitis=painfull swelling of the whole digit caused by inflammation
  • #### PLEASE DO NOT DELETE CONTENT BELOW THIS LINE ! ####
    ########### Presentation 'REM_OPT05_AS_r02_02SEP10.ppt' created on Thursday, 2 September, 2010 ###########
    Author: GIB1 Purpose: Optimize slide decks QA: 27-Mar-09 Review By: 18-Sep-09
    Review Type: Scientific, Reference Check, Compliance Review and HCC Office Slide: 21/168 Golimumab-Specific Deck: No
  • Pictures from the CRI website (http://www.cri-net.com/)
    #### PLEASE DO NOT DELETE CONTENT BELOW THIS LINE ! ####
    ########### Presentation 'REM_OPT05_AS_r02_02SEP10.ppt' created on Thursday, 2 September, 2010 ###########
    Author: GIB1 Purpose: Optimize slide decks QA: 27-Mar-09 Review By: 18-Sep-09
    Review Type: Scientific, Reference Check, Compliance Review and HCC Office Slide: 22/168 Golimumab-Specific Deck: No
  • #### PLEASE DO NOT DELETE CONTENT BELOW THIS LINE ! ####
    ########### Presentation 'GLM_OPT02_GLM Optimize PsA_r00_05AUG10.ppt' created on Wednesday, 4 August, 2010 ###########
    Author: GIB1 Purpose: Optimize slide decks QA: 04-Aug-10 Review By: 04-Feb-11
    Review Type: Scientific, Reference Check, Compliance Review and HCC Office Slide: 15/108 Golimumab-Specific Deck: Yes
  • Sensitivity 82.9%, specificity 84.4%; n=649 patients with chronic back pain and age at onset <45 yrs.
    Imaging arm (sacroiliitis) alone has a sensitivity of 66.2% and a specificity of 97.3%. ** Note: Elevated CRP is considered
    a SpA feature in the context of chronic back pain
    #### PLEASE DO NOT DELETE CONTENT BELOW THIS LINE ! ####
    ########### Presentation 'REM_OPT05_AS_r02_02SEP10.ppt' created on Thursday, 2 September, 2010 ###########
    Author: GIB1 Purpose: Optimize slide decks QA: 27-Mar-09 Review By: 18-Sep-09
    Review Type: Scientific, Reference Check, Compliance Review and HCC Office Slide: 101/168 Golimumab-Specific Deck: No
  • Psoriatic arthritis is an inflammatory disease, the manifestations of which may include:
    Inflammatory arthritis which over time typically progresses to involve greater numbers of joints and can result in joint damage in over 40% of patients
    Psoriasis
    Diffuse swelling of the fingers and toes known as dactylitis
    Enthesitis, which is the inflammation of the point of insertion of tendons, ligaments or joint capsules into bone. Shown here is swelling in the ankle region resulting from the inflammation of the Achilles tendon at the point of insertion into the heel. This is a common site of enthesopathy.
  • #### PLEASE DO NOT DELETE CONTENT BELOW THIS LINE ! ####
    ########### Presentation 'OPTIMize_Pso_core_24NOV08.ppt' created on Monday, 24 November, 2008 ###########
    Author: SILE QC&C: 24-Nov-08 Review By: 24-May-09
    Medical Review: Yes Slide: 11/131
    ########### Presentation 'OPTIMize_Pso_core_14MAY09.ppt' created on Thursday, 14 May, 2009 ###########
    Author: SILE QC&C: 14-May-09 Review By: 24-Oct-09
    Medical Review: Yes Slide: 1/131
  • 1Moll JMH, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973;3:55-78
    2Gladman DD et al. Q J Med. 1987;62(238):127-41
    3Torre Alonso JC et al. Br J Rheumatol. 1991;30(4):245-50
    4Helliwell PS & Taylor WJ, Ann Rheum Dis 2005;64:3-8
    5 Gladman et al. Derm therapy 2009;22:40-55
    It is important to note that since the original Moll and Wright publication of 1973, the proportion of each subgroup has been changed. The symmetric polyarthritis in the original publication was only 15% and now was shown to be the predominant group. The last 3 bullet points are as in Moll&Wright’s ref.
    Helliwell & Taylor, ARD, 2005: Fig.1 shows different distributions of Sym. PolyA and Asym. OligoA according to different references.
    For a recent review on SUBTYPES of PsA, PsA classification and a suggestion for a NEW classification, check out Coates & Helliwell, Clinical Rheumatology, July 2008.
    Ref1973 Moll1987 Gladman1991 Torre
    -----------------------------------------------------------------------------------------------------------------------------
    DIP<5%DIP involvement
    found in all groups-----------------------------------------------------------------------------------------------------------------------------
    Arth. Mutilans5%4%
    -----------------------------------------------------------------------------------------------------------------------------
    Symmetric Arth.15% (= PolyA?)30.5% sym PolyA*37% OligoA
    + 36% PolyA
    No differentiation
    ------------------------------------------------------------------------------------------------between symA and
    Asymmetric Arth.>70% OligoA28% Asym. OligoAasymA.
    + MonoA+ 30.5% asym PolyA*
    -----------------------------------------------------------------------------------------------------------------------------
    Ankyl.Arth.5%23% SpondA
    -----------------------------------------------------------------------------------------------------------------------------
    HLA-B27Not mentionedNot mentioned
    ########## Presentation updated on Wednesday, 4 August, 2010 by GIB1 ##########
    ########## Presentation updated on Thursday, 18 September, 2008 by ANDO ##########
    ########### Presentation updated on Wednesday, 4 August, 2010 ###########
    Author: GIB1 Purpose: Optimize slide decks QA: 04-Aug-10 Review By: 04-Feb-11
    Review Type: Scientific, Reference Check, Compliance Review and HCC Office Slide: 16/108 Golimumab-Specific Deck: Yes
    associated with SpondA
    -----------------------------------------------------------------------------------------------------------------------------
    *Torre, 1991, talks about 61% PolyA, with equal repartition of sym.A and asymA.
     
  • Inflammatory arthritis an overview

    1. 1. Understanding inflammatory arthritis Evaluation and Management principles
    2. 2. CDC: Census Bureau 2004
    3. 3. 3 What is inflammation?  Normal body defence mechanism  Increased blood flow  Blood cells produce chemical messengers to continue the process  Heat, swelling, redness, pain, loss of function
    4. 4. Acute vs Chronic Inflammatory Arthritis Acute Arthritis Rapid onset (hours or days) Severe symptoms Mediated by components of innate immune response, especially neutrophils (proteases, leukotrienes, prostaglandins Can result in rapid joint destruction Can also evolve into chronic disease Examples: Gout and Infectious Arthritis Chronic Arthritis More gradual onset (days to weeks) Symptoms are more moderate, AM stiffness is a prominent symptom Mediated by the adaptive immune response, especially T cells and macrophages - a Th1 disease Cytokines and chronic inflammation lead to joint remodeling and destruction via erosions Examples: Rheumatoid Arthritis, Ankylosing Spondylitis, SLE, Lyme Disease
    5. 5. Diversity of Rheumatologic Diseases: Inflammatory and Immune Responses Inflammatory Diseases (innate immunity) Osteoarthritis Gout Pseudogout Immunologically-Mediated Diseases (adaptive immunity) Rheumatoid Arthritis* Systemic Lupus Erythematosus Spondyloarthropathies* Ankylosing spondylitis * Reactive Arthritis (Reiter’s Syndrome) Psoriatic Arthritis * Spondylitis associated with IBD Sjogren’s Syndrome Polymositis/Dematomyositis Lyme Disease Rheumatic Fever Behcet’s Syndrome Systemic Sclerosis (Scleroderma) Wegener’s Granulomatosis Giant Cell Arteritis * Diseases that will be covered in depth later in lecture of this course.
    6. 6. Pattern of Joint Involvement is Distinct in Different Diseases Monoarticular vs Polyarticular Mono Poly Gout RA Infection SLE Reactive Joint distribution PIPs and MCPs: RA, SLE DIPs: Osteoarthritis, Psoriatic MTP: Gout Symmetrical vs Asymmetrical Symmetrical: RA, SLE Asymmetrical: Psoriatic, Reactive
    7. 7. Multiple Factors Contribute to the Development of Arthritis Nature Reviews Immunology, 2007
    8. 8. Genetic Basis of Rheumatic Diseases: Genotype contributes to rheumatic disease susceptibility ________ Twin Studies____________ Monozygotic Dizygotic Genetic Component Disease Concordance (%) Concordance (%) Explained by HLA (%) Rheumatoid Arthritis 15-34 0-6 35 SLE 25-57 0-3 Ankylosing Spondylitis 50-75 13-18 37 ______________________________________________________________________________ Most often rheumatic diseases are polygenic. A certain genotype predisposes an individual to a disease, but does not make disease development a certainty.
    9. 9. October 2009: >30 RA Risk Loci Plenge RM, ACR Annual Meeting Presentation, October 2009 Together explain ~35% of the genetic burden of disease HLA DR4 “Shared epitope” hypothesis PADI4 PTPN22 CTLA 4 TNFAIP4 STAT4 TRAF1-C5 IL2-IL21 CD40 CCL21 CD244 IL2RB TNFRSF14 PRKCQ PIP4K2C IL2RA AFF3 REL BLK TAGAP CD28 TRAF0 PTPRC FCGR2A PRDM1 CD2-CD58 1978 1987 2003 20072004 2005 2008 2009
    10. 10. Oral Health and RA  Periodontal disease more common in people with RA than controls  Oral bacterium, Porphyromonas gingivalis, may be the connection x Associated with autoantibodies (CCP) x Could be part of causal pathway x Many ongoing studies of role in RA Rosenstein ED et al. Inflammation 2004;28:311-8
    11. 11. 11 Symptoms  Joint pain  Joint swelling  Morning stiffness  Fatigue  Weight loss  Flu-like symptoms
    12. 12. 12
    13. 13. 13
    14. 14. Rheumatoid Arthritis: PIP Swelling  Swelling is confined to the area of the joint capsule  Synovial thickening feels like a firm sponge
    15. 15. Rheumatoid Arthritis: Ulnar Deviation and MCP Swelling  An across-the-room diagnosis  Prominent ulnar deviation in the right hand  MCP and PIP swelling in both hands  Synovitis of left wrist
    16. 16. Rheumatoid Arthritis Early erosion at the tip of the ulnar styloid
    17. 17. 2010 ACR/EULAR Classification Criteria for RA JOINT DISTRIBUTION (0-5) 1 large joint 0 2-10 large joints 1 1-3 small joints (large joints not counted) 2 4-10 small joints (large joints not counted) 3 >10 joints (at least one small joint) 5 SEROLOGY (0-3) Negative RF AND negative ACPA 0 Low positive RF OR low positive ACPA 2 High positive RF OR high positive ACPA 3 SYMPTOM DURATION (0-1) <6 weeks 0 ≥6 weeks 1 ACUTE PHASE REACTANTS (0-1) Normal CRP AND normal ESR 0 Abnormal CRP OR abnormal ESR 1 ≥6 = definite RA What if the score is <6? Patient might fulfill the criteria…  Prospectively over time (cumulatively)  Retrospectively if data on all four domains have been adequately recorded in the past
    18. 18. 18 Extraarticular ?  Eyes: dryness, inflammation, uveitis  Lungs: fluid, inflammation, nodules  Skin: nodules, ulcers, psoriasis, balanitis, keratoderma blenorhagia  Heart: fluid, inflammation, ischaemic heart disease  Blood: anaemia, low counts
    19. 19. Spondyloarthritis, Psoriasis and PsA Spondyloarthritis (SpA)  The prevalence of SpA is comparable to that of RA (0.5–1.9%)1,2 Psoriasis (Pso)  Psoriasis affects 2% of population  7% to 42% of patients with Pso will develop arthritis3 Psoriatic Arthritis  A chronic and inflammatory arthritis in association with skin psoriasis4  Usually rheumatoid factor (RF) negative and ACPA negative5 x Distinct from RA  Psoriatic Arthritis is classified as one of the subtypes of spondyloarthropathies x Characterized by synovitis, enthesitis, dactylitis, spondylitis, skin and nail psoriasis4 1 Rudwaleit M et al. Ann Rheum Dis 2004;63:535-543; 2 Braun J et al. Scand J Rheumatol 2005;34:178-90; 3 Fitzgerald “Psoriatic Arthritis” in Kelley’s Textbook of Rheumatology, 2009; 4 Mease et al. Ann Rheum Dis 2011;70(Suppl 1):i77–i84. doi:10.1136/ard.2010.140582; 5 Pasquetti et al. Rheumatology 2009;48:315–325 Juvenile SpA Reactive arthritis Arthritis associated with IBD PsA Undifferentiated SpA (uSpA) Ankylosing spondylitis (AS) RA: Rheumatoid arthritis
    20. 20. AS: A Debilitating Rheumatic DiseaseAS: A Debilitating Rheumatic Disease 1 Linden VD et al. Chapter 10. In: Firestein, Budd, Harris, McInnes, Ruddy and Sergent, eds. Kelley’s Textbook of Rheumatology: Spondyloarthropathies. 8th ed. Saunders Elsevier;2009:p.1171 2 Braun J & Sieper. J Rheumatology 2008;47:1738-40
    21. 21. Ankylosing Spondylitis “Bamboo Spine” Repeated process of healing and bone formation leads to formation of syndesmophytes ‘bone bridges’ ACR Slide Collection on the Rheumatic Diseases; 3rd edition. 1994.
    22. 22. • Mortality figures parallel RAMortality figures parallel RA6,7,86,7,8  ““Rare”Rare”  ““Not” a serious disease, functional limitation isNot” a serious disease, functional limitation is mildmild  ““Rarely shortens life”Rarely shortens life” AS (“Mis-”) Perceptions • Burden of disease significant in pain, sick leave, earlyBurden of disease significant in pain, sick leave, early retirementretirement3,4,53,4,5 • 0.1-0.9%0.1-0.9%1,21,2 11 Sieper J et al.Sieper J et al. Ann Rheum Dis.Ann Rheum Dis. 2002; 61 (suppl 3);iii8-18.2002; 61 (suppl 3);iii8-18. 22 Lawrence RC., Arthritis Rheum 1998; 41:778-99.Lawrence RC., Arthritis Rheum 1998; 41:778-99. 33 Zink A., et al.,Zink A., et al., J RheumatolJ Rheumatol 2000; 27:613-22.2000; 27:613-22. 44 Boonen A.Boonen A. Clin Exp RheumatolClin Exp Rheumatol. 2002;20(suppl 28):S23-S26.. 2002;20(suppl 28):S23-S26. 55 Gran JT, et al.Gran JT, et al. Br J RheumatolBr J Rheumatol. 1997;36:766-771.. 1997;36:766-771. 66 Wolfe F., et al. Arthritis Rheum. 1994 Apr;37(4):481-94.Wolfe F., et al. Arthritis Rheum. 1994 Apr;37(4):481-94. 77 Myllykangas-Luosujarvi R, et al.Myllykangas-Luosujarvi R, et al. Br J Rheumatol.Br J Rheumatol. 1998;37:688-690.1998;37:688-690. 88 Khan MA, et al.Khan MA, et al. J Rheumatol.J Rheumatol. 1981;8:86-90.1981;8:86-90. 99 Braun J., Pincus T., Clin Exp Rheumatol. 2002; 20(6 Suppl 28):S16-22.Braun J., Pincus T., Clin Exp Rheumatol. 2002; 20(6 Suppl 28):S16-22.
    23. 23. AS: Signs and SymptomsAS: Signs and Symptoms Axial manifestations: • Chronic low back pain • With or without buttock pain • Inflammatory characteristics: – Occurs at night (second part) – Sleep disturbance – Morning stiffness • Limited lumbar motion Sengupta R & Stone MA. Nat Clin Pract Rheumatol 2007;3:496-503 Hultgren S et al. Scand J Rheumatol 2000;29:365-369 Linden VD et al. Chapter 10. In: Firestein, Budd, Harris, McInnes, Ruddy and Sergent, eds. Kelley’s Textbook of Rheumatology: Spondyloarthropathies. 8th ed. Saunders Elsevier;2009:p.1175 Inflammatory back pain (IBP) = Characteristic symptom MRI sacro-iliac joint
    24. 24. Peripheral manifestations Enthesitis Peripheral arthritis Dactylitis AS: Signs and SymptomsAS: Signs and Symptoms 50% patients with enthesitis1 1 Cruyssen BV et al. Ann Rheum Dis 2007;66:1072-1077 2 Sidiropoulos PI et al. Rheumatology 2008;47:355-361 Up to 58% patients ever had arthritis1 Much smaller number of patients2
    25. 25. Why are Dactylitis and Enthesitis Important? The first abnormality to appear in swollen joints associated with spondyloarthropathies is an enthesitis2 Likelihood of erosions is higher for digits with dactylitis than those without1 1 Brockbank. Ann Rheum Dis 2005;62:188-90; 2 McGonagle et al. The Lancet 1998;352.
    26. 26. AS: Extra-skeletal Signs and SymptomsAS: Extra-skeletal Signs and Symptoms Other common symptoms seen during the early stages of disease include: • Anorexia • Malaise • Low grade fever • Weight loss • Fatigue 1 Missaoui B. et al. Ann Readapt Med Phys 2006;49:305-8, 389-391 Linden VD et al. Chapter 10. In: Firestein, Budd, Harris, McInnes, Ruddy and Sergent, eds. Kelley’s Textbook of Rheumatology: Spondyloarthropathies. 8th ed. Saunders Elsevier;2009:p.1176 Fatigue is a frequent complaint of patients with AS1
    27. 27. AS:AS: Extra-articular Manifestations (EAM)Extra-articular Manifestations (EAM) EAM Prevalence in AS Patients (%) Anterior uveitis 30-50 IBD 5-10 Subclinical inflammation of the gut 25-49 Cardiac abnormalities Conduction disturbances Aortic insufficiency 1-33 1-10 Psoriasis 10-20 Renal abnormalities 10-35 Lung abnormalities Airways disease Interstitial abnormalities Emphysema 40-88 82 47-65 9-35 Bone abnormalities Osteoporosis Osteopenia 11-18 39-59 Elewaut D & Matucci MC. Rheumatology 2009;48:1029-1035 Terminal ileitis Anterior uveitis Cardiac abnormalities
    28. 28. Spondyloarthritis and Classification Criteria Spondyloarthropathies Axial and Peripheral AMOR criteria (1990) ESSG criteria (1991) Axial Spondyloarthritis ASAS classification 2009 Ankylosing spondylitis Prototype of axial spondylitidis Modified New York criteria 1984 Peripheral Spondyloarthritis ASAS classification 2010 Psoriatic arthritis From Moll & Wright 1973 to CASPAR criteria 2006 Sieper et al. Ann Rheum Dis 2009;68:ii1-ii44 Taylor et al. Arthritis & Rheum 2006;54:2665-73 Van der Heijde et al. Ann Rheum Dis 2011;70:905-8 ESSG: European Spondyloarthropathy Study Group ASAS: Assessment of Spondyloarthritis International Society CASPAR: Classification criteria for psoriatic arthritis Infliximab (IFX) and Golimumab (GLM) indications
    29. 29. ASAS Classification Criteria for Axial SpAASAS Classification Criteria for Axial SpA In patients with back pain ≥3 months and age at onset <45 years Sacroiliitis* on imaging plus ≥1SpA feature** HLA-B27 plus ≥2 other SpA features** **SpA features: •Inflammatory back pain •Arthritis •Enthesitis (heel) •Uveitis •Dactylitis •Psoriasis •Crohn’s disease/ulcerative colitis •Good response to NSAIDs •Family history for SpA •HLA-B27 •Elevated CRP *Sacroiliitis on imaging: •Active (acute) inflammation on MRI highly suggestive of sacroiliitis associated with SpA or •Definite radiographic sacroiliitis according to modified New York criteria Rudwaleit M et al. Ann Rheum Dis 2009;68(6):770-6 OR
    30. 30. 30 Psoriatic Arthritis
    31. 31. Psoriatic Arthritis ACR Slide Collection on the Rheumatic Diseases; 3rd edition. 1994. Data on file, Centocor, Inc.
    32. 32. Pso patients6-8 • Psychosocial burden • Reactive depression • Higher suicidal ideation • Alcoholism  Metabolic Syndrome3-5 • Hyperlipidemia • Hypertension • Insulin resistent • Diabetes • Obesity ⇒ Higher risk of Cardiovascular disease (CVD) Ocular inflammation1 (Iritis/Uveitis/ Episcleritis) IBD2 Comorbidities in PsA Patients 1 Qieiro et al. Semin Arth Rheum 2002;31:264; 2 Scarpa et al. J Rheum 2000;27:1241; 3 Mallbris et al. Curr Rheum Rep 2006;8:355; 4 Neimann et al. J Am Acad Derm 2006;55:829; 5 Tam et al. 2008;47:718; 6 Kimball et al. Am J Clin Dermatol 2005;6:383-392; 7 Naldi et al. Br J Dermatol 1992;127:212-217; 8 Mrowietz U et al. Arch Dermatol Res 2006;298(7):309-319
    33. 33. Classical Description of PsA Using the Diagnostic Criteria of Moll and Wright  Including 5 clinical patterns: x Asymmetric mono-/oligoarthritis (~30% [range 12-70%])1-4 x Symmetric polyarthritis (~45% [range 15-65%])1-4 x Distal interphalangeal (DIP) joint involvement (~5%)1 x Axial (spondylitis and Sacroiliitis) (HLA-B27) (~5%)1,3 x Arthritis Mutilans (<5%)1,3 References see notes • However patterns may change over time and are therefore not useful for classification 5 HLA: Human leucocytes antigen
    34. 34. Paradigm shift in the treatment of inflammatory arthritis  Rationale for Treatment x Large body of evidence which shows joint damage is an early phenomenon of rheumatoid arthritis x Joint erosions occur in up to 93% of patients with less than 2 years of disease activity x The rate of radiographic progression is greatest in the first two years x Disability occurs early – 50% of patients with RA will be work disabled at 10 years x Severe disease is associated with increased mortality!
    35. 35. It’s like an Iceberg
    36. 36. It’s what you don’t see!
    37. 37. Approach to Inflammatory Arthritis  “Window of Opportunity” x Early and aggressive treatment may have long-term benefits  Principles of Treatment x Treat Early x Treat Appropriately
    38. 38. A Fire in the Joints If there’s a fire in the kitchen do you wait until it spreads to the living room or do you try and put it out?
    39. 39. 39 Principles of Treatment  Early diagnosis  Early initiation of treatment  Regular assessment (Disease Activity Scores)  “Treat to Target”  Annual review
    40. 40. 40 Reduction of Joint Damage Disease-modifying Anti- Rheumatic Drugs Methotrexate Sulfasalazine Leflunomide Hydroxychloroquine Azathioprine Ciclosporin Gold Penicillamine Biologic drugs  Anti-TNF therapy:  Infliximab  Etanercept  Adalimumab  Certolizumab  Golimumab  Rituximab  Abatacept  Tocilizumab
    41. 41. 41
    42. 42. 42
    43. 43. 43

    ×